This article was written for The Conversation and is reprinted under Creative Commons license.
Problems with sleep are common. In recent research, 48% of UK adults said sleeping badly had a negative effect on their mental health. For teenagers, this proportion was significantly higher – 66%.
The large number of people experiencing sleep problems makes for an attractive market. Some companies have seized the opportunity to provide remedies, including several manufacturers of cannabis products.
Changes to the way cannabis is regulated in many countries, including the UK, have helped the boom in cannabis products, with more people able to access these types of offerings – even if the cannabis compounds that can be used in sleep products in some countries are more limited than in others. In the US, where cannabis is fully legal in many states, California-based Ganja Goddess reported more than a sevenfold increase in revenue for its cannabis sleep products during the first year of the COVID pandemic.
But what is the evidence that cannabis products can help people get a better night’s sleep?
Cannabis and sleep
Sleep disturbance is a common feature of withdrawal from cannabis use, indicating there may well be a relationship between cannabis use and sleep. But we still don’t have a clear understanding of the mechanisms in the brain involved in this relationship.
The effects of cannabis are due to a group of chemicals in the drug called cannabinoids. These include cannabidiol (CBD), cannabinol (CBN) and tetrahydrocannabinol (THC). THC is the psychoactive substance in cannabis. CBN and CBD don’t cause you to get high in the same way.
In the UK, CBD products are available legally, providing they don’t contain more than 0.2% THC. Retailers and suppliers make all kinds of assertions about the benefits of CBD products, including how CBD can improve sleep. There is some evidence to support these claims, but this is mainly based on animal and human observational studies rather than randomised control trials, where comparisons can be made between CBD and a placebo.
Although not legal in the UK, CBN is one of the main compounds contained in commercial cannabis sleep products, with more and more CBN formulations coming onto the market. A recent review sought to find out whether CBN really does improve sleep.
The review included studies going back as far as the 1940s. These mainly involved administering CBN to people and comparing the self-reported quality of their sleep with participants in a control group who had not received the drug.
However, the author of the review, Jamie Corroon, noted several problems with the research to date, including the fact that participants tended to be male and white. This male-centric perspective is not unique to research on cannabis; it’s known to be a problem more broadly in research.
Corroon was also critical of the lack of structured, evidence-based questionnaires used to assess sleep in the studies. He concluded there is insufficient published evidence to support any assertions that these products improve sleep, noting: “Individuals seeking cannabis-derived sleep aids should be skeptical of manufacturers’ claims of sleep-promoting effects.”
Other factors to consider
The review concentrated primarily on sleep outcomes associated with pure medical-grade CBN. This doesn’t necessarily reflect the way most people use cannabis or cannabis products. Most will either smoke a joint, or ingest a liquid or pill if they’re using a commercially supplied product.
The type of commercial product, the way it’s administered and the dose are all known to affect sleep. Notably, the dose of CBN in many commercial products is lower than what was tested in the majority of the studies in the review.
While most commercial cannabis sleep products contain less than 1% THC (if any), a cannabis joint will contain hundreds of compounds, including THC. And combining THC with CBN is thought to be a sedative. Pure CBN would therefore not have the same effect it has in real life when consumed with THC.
Although the review found a lack of evidence to support the sedative properties of CBN, scientists have found that medicinal cannabis containing THC and CBD can improve sleep for people with chronic pain. This benefit decreases, however, for people using these products regularly, as their tolerance to medicinal cannabis builds.
Further, while it’s useful to have a review that focuses on sleep and cannabis, it doesn’t capture the varied reasons many people use cannabis or products containing cannabis. Many people use cannabis to manage physical problems such as muscle and joint pain, or psychological issues like anxiety or stress, rather than as a sleep aid. It’s logical that alleviating these symptoms will improve sleep.
One example is people experiencing vivid nightmares as a result of post-traumatic stress disorder (PTSD). Nabilone, a synthetic cannabinoid, has proved to be beneficial in suppressing these types of nightmares, which could improve the quality of sleep for this group of people suffering from PTSD. So you can see why it’s difficult to untangle the effects of cannabis on sleep.
We need better research
As with many issues in research, there isn’t a neat answer to how effective cannabis is in improving sleep. How the drug is prepared, the way it’s taken and the person’s expectations are just some important factors that may influence the outcome.
And, as with all health products, there is a risk of side-effects. A recent review of medicinal cannabis products used for sleep found a substantial increase in the risk of developing dizziness, for example.
What is clear is when millions of people have a problem with sleep, there will be a commercial incentive to make money by offering remedies. We need more rigorous research to investigate any associations between cannabis and sleep, and whether these products work.
The Conversation is a nonprofit, independent news organization dedicated to unlocking the knowledge of experts for the public good. We publish trustworthy and informative articles written by academic experts for the general public and edited by our team of journalists.
- Commentary: It’s time for Biden to keep his promises on cannabisPaul Armentano, the deputy director of the National Organization for the Reform of Marijuana Laws (NORML), calls on President Joe Biden to live up to the pledges made during his campaign regarding cannabis legalization.
- Unofficial totals show Missouri cannabis legalization initiative shortAn initiative to legalize recreational marijuana use in Missouri will need help if it is going to be on the November ballot. Reports from every county in the state show the petition is short of its goal in two of the six congressional districts needed to qualify for the ballot.
- Fate of Missouri cannabis initiative unclear as signature count continuesWhether Missouri voters will get a chance to legalize recreational marijuana in November is still in question. The latest incomplete tabulations show the Legal Missouri 2022 initiative is short of the necessary signatures in four of the six Congressional districts necessary to make the ballot.
- ACLU of NV suit to deschedule cannabis statewide survives challengeA legal effort by the ACLU of Nevada to force the Nevada Board of Pharmacy to remove cannabis from its Schedule 1 of controlled substances will proceed, Clark County Judge Joe Hardy ruled Wednesday when he denied the board’s motion to dismiss the ACLU’s lawsuit.
- Advocates, parents ‘beg’ Nebraskans to seek out and sign petition to legalize medical cannabisAdvocates for legalizing medical marijuana switched Wednesday from urging Nebraskans to sign their petition to begging them as a July 7 deadline looms to submit signatures to qualify for the ballot in November.
- Iowans launch cannabis reform campaign aimed at showing public supportRobert “Lewy” Lewis of Windsor Heights has been in pain since 1974, when he had spinal surgery at the age of 21. To repair a blockage in his spine, surgeons removed eight inches of his vertebrae and then sewed them back on, using about 300 steel stitches.
- Big Apple Cannabis: CWCB Returns to New York City for Eighth Year“No one seems to have gotten it right.” Mayor Eric Adams told a Friday afternoon crowd, of legal cannabis in America. “This is our chance to get it right.” New York City’s mayor addressed attendees of the 2022 Cannabis World Congress & Business Expo (CWCBExpo) on the second day of the three-day event. Adams stressed the social equity focus of New York’s cannabis program.
- Nebraska medical cannabis backers file legal challenge to petition processSupporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot.
- N.J. lawmakers seek to curb cannabis useAs New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job.
- Missouri House votes to require disclosure of medical cannabis ownership recordsThe Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view.